Literature DB >> 11782993

Selective hippocampal neuron loss in dementia with Lewy bodies.

Antony J Harding1, Bronwyn Lakay, Glenda M Halliday.   

Abstract

Hippocampal volume and neuron number were measured using stereological techniques in pathologically confirmed dementia with Lewy bodies (n = 8), Parkinson's disease only (n = 4), and controls (n = 9). We, and others, have previously shown considerable cell loss in the CA1 and subiculum subregions in Alzheimer's disease. In contrast, these regions were spared in dementia with Lewy bodies where a selective loss of lower presubiculum pyramidal neurons was found. These findings suggest a selective loss of frontally projecting hippocampal neurons in dementia with Lewy bodies versus those projecting to temporal lobe regions in Alzheimer's disease.

Entities:  

Mesh:

Year:  2002        PMID: 11782993     DOI: 10.1002/ana.10071

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  19 in total

1.  Effects of Alpha-Synuclein on Primary Spinal Cord Neurons Associated with Apoptosis and CNTF Expression.

Authors:  Guo-Ying Feng; Jia Liu; You-Cui Wang; Zhen-Yu Wang; Yue Hu; Qing-Jie Xia; Yang Xu; Fei-Fei Shang; Mei-Rong Chen; Fang Wang; Xue Zhou; Ting-Hua Wang
Journal:  Cell Mol Neurobiol       Date:  2016-08-31       Impact factor: 5.046

2.  Hydrogen peroxide responsive miR153 targets Nrf2/ARE cytoprotection in paraquat induced dopaminergic neurotoxicity.

Authors:  Madhusudhanan Narasimhan; Amanjot Kaur Riar; Mary Latha Rathinam; Dhanashree Vedpathak; George Henderson; Lenin Mahimainathan
Journal:  Toxicol Lett       Date:  2014-05-24       Impact factor: 4.372

3.  Evidence for the involvement of apoptosis-inducing factor-mediated caspase-independent neuronal death in Alzheimer disease.

Authors:  Wenfeng Yu; Naguib Mechawar; Slavica Krantic; Rémi Quirion
Journal:  Am J Pathol       Date:  2010-03-12       Impact factor: 4.307

4.  Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.

Authors:  Diana L Price; Edward Rockenstein; Kiren Ubhi; Van Phung; Natalie MacLean-Lewis; David Askay; Anna Cartier; Brian Spencer; Christina Patrick; Paula Desplats; Mark H Ellisman; Eliezer Masliah
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

5.  α-Synuclein induces alterations in adult neurogenesis in Parkinson disease models via p53-mediated repression of Notch1.

Authors:  Paula Desplats; Brian Spencer; Leslie Crews; Pruthul Pathel; Dinorah Morvinski-Friedmann; Kori Kosberg; Scott Roberts; Christina Patrick; Beate Winner; Juergen Winkler; Eliezer Masliah
Journal:  J Biol Chem       Date:  2012-07-25       Impact factor: 5.157

6.  Alpha-synuclein alters Notch-1 expression and neurogenesis in mouse embryonic stem cells and in the hippocampus of transgenic mice.

Authors:  Leslie Crews; Hideya Mizuno; Paula Desplats; Edward Rockenstein; Anthony Adame; Christina Patrick; Beate Winner; Juergen Winkler; Eliezer Masliah
Journal:  J Neurosci       Date:  2008-04-16       Impact factor: 6.167

Review 7.  Dementia with Lewy bodies.

Authors:  Tanis J Ferman; Bradley F Boeve
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

8.  Critical appraisal of pathology transmission in the α-synuclein fibril model of Lewy body disorders.

Authors:  Negin Nouraei; Daniel M Mason; Kristin M Miner; Michael A Carcella; Tarun N Bhatia; Benjamin K Dumm; Dishaben Soni; David A Johnson; Kelvin C Luk; Rehana K Leak
Journal:  Exp Neurol       Date:  2017-10-19       Impact factor: 5.330

Review 9.  Neuritic alterations and neural system dysfunction in Alzheimer's disease and dementia with Lewy bodies.

Authors:  J Klucken; P J McLean; E Gomez-Tortosa; M Ingelsson; Bradley T Hyman
Journal:  Neurochem Res       Date:  2003-11       Impact factor: 3.996

Review 10.  Dementia with Lewy bodies: disease concept and genetics.

Authors:  Manuel B Graeber; Ulrich Müller
Journal:  Neurogenetics       Date:  2003-07-26       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.